Science
Mechanism of Action
Cobrotoxin exerts its primary action by binding antagonistically and slowly reversibly to nicotinic acetylcholine receptors (nAChRs) on nerve and muscle tissues, thereby blocking acetylcholine signaling and inducing paralysis. In the context of skin inflammation, it demonstrates anti-allergic and anti-inflammatory activity by modulating IL-33 expression in keratinocytes, reducing IgE secretion from B cells, and inhibiting mast cell degranulation and inflammatory cytokine production.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Direct Cobrotoxin is not commonly incorporated into cosmetic formulations due to its inherent toxicity and lack of specific regulatory safety assessments for cosmetic use. Instead, synthetic peptides designed to mimic its muscle-relaxing effects (e.g., SYN-AKE) are utilized.
The Formula
Formulation
Stability
Cobrotoxin's toxicity remains stable after heat treatment, specifically after heating for 30 minutes at 80°C in an acetate buffer at pH 5.8.
Conflicts
- High salt concentrations can interfere with Cobrotoxin's binding to nicotinic acetylcholine receptors (nAChRs), potentially diminishing its neurotoxic activity and thus its intended biological effects.
Safety
Safety Profile
No direct safety assessment by major regulatory bodies (CIR, SCCS, FDA) for Cobrotoxin as a cosmetic ingredient has been identified. The scientific community generally advises against the direct application of venoms, favoring synthetic mimics for cosmetic purposes due to safety concerns.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While demonstrating promising anti-inflammatory and anti-allergic properties in preclinical studies, direct Cobrotoxin is considered questionable for cosmetic use due to its inherent neurotoxicity and the absence of established safety assessments for human topical application.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources